Funding Search - Pivot

The University of Vermont, through Sponsored Project Administration (SPA) subscribes to Pivot, a web-based funding search tool. The UVM Cancer Center has collaborated with SPA to create a customized cancer relevant pivot search. Press the button for Cancer Funding Opportunities.

Cancer Funding Opportunities

If you would prefer to set up your own pivot search and automated alerts you can learn more about pivot HERE.

For Pivot Assistance

Please review the information provided by SPA

Hilda Alajajian, Grant Resources Specialist is available to meet with individuals or groups for assistance in identifying funding

Phone: (802)656-1322

Should you learn of an opportunity not listed here but important to UVM Cancer Center research, please contact Laura Gordon.

Limited Competition Funding

Please contact Edward North for information on applying for Limited Funding Opportunities. 

Peer-Reviewed Funding Sources

Below is a list of fund sources from federal agencies, non-profit foundations and regional and national organizations to support cancer research are provided below for UVM Cancer Center researchers. This of funding is considered NCI approved peer-reviewed funding and can also be found in PDF format at the following link: NCI Peer-Reviewed Fund Sources

  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex’s Lemonade Stand Foundation (ALSF)
  3. American Association of Cancer Research (AACR)
  4. American Cancer Society (ACS) (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA) (excluding local/regional & “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program (NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *

Highlights: New & Updated

New and Updated

Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Not Allowed- (RFA-HL-20-001)

Physician scientists must be in mentored, training positions to be eligible to apply to this K99 program. Clinicians (including those with M.D., D.O. and other licensed professionals) in positions not designated as postdoctoral positions are eligible if they hold a clinical faculty position that denotes independence in clinical responsibilities but not in research. A clinical faculty member who does not hold an independent research faculty position may be eligible for this program, and should contact the NHLBI Program Director for guidance. If an applicant achieves research independence before a K99 award is made, the K99 award will not be issued.

Application Receipt Date(s): March 1, 2019; March 2, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

LIMITED: Mary Kay Foundation -

has invited one application from UVM for a $100,000 grant to support innovative translational research in ovarian, uterine, breast, or cervical cancer, details of which may be found in the attached RFP.

If you’re interested in applying to be the UVM candidate, please submit the attached pre-application by Monday December 17, 2018 at noon so we can choose the best candidate before the winter break. This will ensure the successful applicant has sufficient time to complete the full proposal, which is due to Mary Kay by February 8, 2019 at 5:00 PM Central Time.

More information on the Mary Kay Foundation, including the 2018 grant recipients, can be found at

The Fiscal Year 2019 Department of Defense Appropriations Act provides research funding for a number of cancer-relevant research areas, following peer reviewed programs managed by the Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP). Areas include lung, prostate, and ovarian cancers, and, new this year (2019), melanoma. Click here for more information.

Pediatric Cancer Research Foundation grants; multiple opportunities. Deadline is May 1, 2019.

DoD Ovarian Cancer Research Program - Early Career Investigator Award; maximum $725,000 over four
years; interactive award with education included. Pre-application due July 25,